Chancellor Rachel Reeves Plans Targeted Measures on Bills in Forthcoming Financial Plan
Treasury head Reeves has announced she is preparing "targeted measures to address household expense issues" in the upcoming Budget.
Speaking to the BBC, she noted that curbing price rises is a joint duty of both the administration and the central bank.
The UK's inflation rate is projected to be the highest among the G7 industrialized countries this calendar year and the following year.
Possible Energy Cost Interventions
It is understood the administration could take action to bring down energy bills, such as by reducing the present 5% rate of value-added tax applied on energy.
A further option is to lower some of the policy costs currently added to bills.
Fiscal Limitations and Expert Predictions
The administration will obtain the next assessment from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will clarify how much room there is for these measures.
The expectation from the majority of economists is that Reeves will have to announce tax increases or budget cuts in order to fulfill her self-imposed borrowing rules.
Earlier on the same day, analysis indicated there was a twenty-two billion pound gap for the Treasury chief to resolve, which is at the lower end of projections.
"There's a shared job between the central bank and the government to bear down further on some of the sources of inflation," the Chancellor told reporters in the US capital, at the yearly gatherings of the International Monetary Fund and World Bank.
Tax Pledges and Global Concerns
While a great deal of the attention has been on probable tax rises, the Treasury chief said the latest figures from the OBR had not altered her vow to manifesto promises not to increase rates on earnings tax, VAT or social security contributions.
She blamed an "uncertain global environment" with increasing international and trade concerns for the Budget revenue measures, likely to be directed on those "wealthiest."
International Economic Tensions
Addressing apprehensions about the United Kingdom's commercial links with China she said: "The UK's security interests always are paramount."
Recent statement by Chinese authorities to strengthen trade restrictions on critical minerals and other resources that are essential for high-technology manufacturing led American leader the US President to suggest an further 100% import tax on goods from China, raising the risk of an full-scale commercial conflict between the two largest economies.
The American finance chief called China's move "commercial pressure" and "a international production power grab."
Asked about accepting the American proposal to join its conflict with China, Reeves said she was "extremely troubled" by China's actions and encouraged the Chinese government "to avoid restrictions and limit trade."
She said the decision was "bad for the global economy and causes additional headwinds."
"In my view there are areas where we need to challenge China, but there are also important chances to export to China's economy, including banking sector and other areas of the economy. We've got to maintain that equilibrium appropriate."
The Treasury chief also affirmed she was collaborating with international partners "regarding our own essential resources approach, so that we are reduced dependence."
Health Service Drug Costs and Investment
Reeves also admitted that the price the NHS spends on medicines could rise as a consequence of ongoing talks with the Trump administration and its drugs companies, in exchange for reduced taxes and investment.
A number of the biggest global drug companies have said recently that they are either halting or canceling projects in the UK, with several attributing the modest returns they are obtaining.
Recently, the Science Minister said the cost the health service pays for medicines would must rise to prevent companies and drug research funding departing from the United Kingdom.
The Chancellor told media: "We have seen due to the cost structure, that medical research, innovative medicines have not been offered in the United Kingdom in the extent that they are in other EU nations."
"Our aim is to guarantee that people getting care from the NHS are able to access the finest essential medicines in the globe. And so we are reviewing these issues, and... looking to obtain increased funding into the UK."